Inside Indiana Business explains necrotic enteritis for a general business audience and what BiomEdit does next after conditional licensure, noting the disease costs the broiler industry up to $6 billion annually.
Source: Inside INdiana Business
Back to News
Inside INdiana Business · October 15, 2026
BiomEdit ready to advance development of first commercial product after initial approval
Inside Indiana Business explains necrotic enteritis for a general business audience and what BiomEdit does next after conditional licensure, noting the disease costs the broiler industry up to $6 billion annually.
